Mariadele Noe

Title: Mariadele Noe: Innovator in Tumor Necrosis Factor Inhibition

Introduction

Mariadele Noe is a prominent inventor based in Haddonfield, NJ (US). She has made significant contributions to the field of medical research, particularly in the development of compounds that inhibit tumor necrosis factor (TNF) activity. Her work has the potential to impact the treatment of various diseases and disorders mediated by TNF-alpha.

Latest Patents

Mariadele Noe holds a patent for "Tumor necrosis factor inhibitors - TNF.alpha. antagonist compounds and methods of using the same." This patent discloses compounds that comprise a molecular surface substantially similar to at least one molecular surface of human TNF-alpha. The compounds are designed to bind to TNF receptors without producing the same biological effects as TNF-alpha. The methods outlined in her patent include inhibiting TNF activity by contacting it with a TNF-alpha antagonist and treating individuals suspected of suffering from diseases mediated by TNF-alpha activity.

Career Highlights

Throughout her career, Mariadele Noe has been associated with Thomas Jefferson University, where she has contributed to groundbreaking research in her field. Her innovative approach to understanding and manipulating TNF-alpha has positioned her as a key figure in medical research.

Collaborations

Mariadele Noe collaborates with her coworker, Bradford A. Jameson, to further advance their research initiatives. Their combined expertise enhances the potential for developing effective treatments based on their findings.

Conclusion

Mariadele Noe's work in tumor necrosis factor inhibition exemplifies the impact of innovative research on medical science. Her contributions are paving the way for new therapeutic approaches to combat diseases associated with TNF-alpha activity.